Cancer News and Research

Latest Cancer News and Research

Study links high and low levels of "good" cholesterol with dementia risk

Having either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increased risk of dementia in older adults, according to a study published in the October 4, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2023

Weill Cornell Medicine researcher receives $610,000 grant to study metastasis in bladder cancer

A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer.

4 Oct 2023

Wood cookstove use linked to gastric cancer risk

Researchers conducted a population-based study with a case–control design in rural areas of Honduras in Central America to examine whether wood cookstove use by indigenous populations was associated with increased risk of stomach cancers, including gastric adenocarcinoma.

4 Oct 2023

Review of Oregon's assisted dying law finds significant data gaps

There are critical gaps in the data provided on doctor assisted deaths in Oregon, USA, amid rising numbers of participants, finds a review of the process over the past 25 years, published online in the journal BMJ Supportive & Palliative Care.

4 Oct 2023

Robotic device could revolutionize how women monitor their breast health

A device has been created that could carry out Clinical Breast Examinations (CBE).

3 Oct 2023

Type 2 diabetes at age 30 linked to shorter life expectancy

An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.

3 Oct 2023

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.

3 Oct 2023

Gene variants linked to higher risk for nodular melanoma identified

Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

3 Oct 2023

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment.

3 Oct 2023

New meningitis vaccine safe and effective for infants in Africa

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.

3 Oct 2023

Research opens the door for better use of people's own immune system T cells to fight cancer

Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people's own immune system T cells to fight cancer.

3 Oct 2023

Machine learning model can identify who needs lung cancer screening

A machine learning model equipped with only data on people's age, smoking duration and the number of cigarettes smoked per day can predict lung cancer risk and identify who needs lung cancer screening, according to a new study publishing October 3rd in the open access journal PLOS Medicine by Thomas Callender of University College London, UK, and colleagues.

3 Oct 2023

IU cancer researcher receives NCI grant to examine how immune cells support breast cancer development

A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development-;and how to stop it.

3 Oct 2023

New discovery could delay relapse in triple-negative breast cancer

A team of researchers at the Medical University of Vienna has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein called P-glycoprotein (P-gp).

3 Oct 2023

Pharmacists can play key role in boosting HPV vaccination rates

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer.

3 Oct 2023

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

3 Oct 2023

Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms

Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms.

3 Oct 2023

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.

3 Oct 2023

MR-linac systems could help clinicians distinguish true progression from pseudoprogression in glioblastoma

Is it true progression or pseudoprogression in tumor growth?

3 Oct 2023

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

3 Oct 2023

Cancer News and Research

Latest Cancer News and Research

Study links high and low levels of "good" cholesterol with dementia risk

Weill Cornell Medicine researcher receives $610,000 grant to study metastasis in bladder cancer

Wood cookstove use linked to gastric cancer risk

Review of Oregon's assisted dying law finds significant data gaps

Robotic device could revolutionize how women monitor their breast health

Type 2 diabetes at age 30 linked to shorter life expectancy

New drugs have increased survival rates for men with metastatic prostate cancer

Gene variants linked to higher risk for nodular melanoma identified

Metabolism-targeting drug could offer new hope for cancer-related fatigue

New meningitis vaccine safe and effective for infants in Africa

Research opens the door for better use of people's own immune system T cells to fight cancer

Machine learning model can identify who needs lung cancer screening

IU cancer researcher receives NCI grant to examine how immune cells support breast cancer development

New discovery could delay relapse in triple-negative breast cancer

Pharmacists can play key role in boosting HPV vaccination rates

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

MR-linac systems could help clinicians distinguish true progression from pseudoprogression in glioblastoma

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in